The preclinical amyloid sensitive composite to determine subtle cognitive differences in preclinical Alzheimer’s disease

Recently, the focus of Alzheimer’s disease (AD) research has shifted from the clinical stage to the preclinical stage. We, therefore, aimed to develop a cognitive composite score that can detect the subtle cognitive differences between the amyloid positive (Aβ+) and negative (Aβ−) status in cognitiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Alice, Kim, Young Ju, Kim, Hee Jin, Jang, Hyemin, Cho, Hanna, Choi, Seong Hye, Kim, Byeong C., Park, Kyung Won, Na, Duk L., Chin, Juhee, Seo, Sang Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423599/
https://www.ncbi.nlm.nih.gov/pubmed/32788669
http://dx.doi.org/10.1038/s41598-020-70386-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423599/
https://www.ncbi.nlm.nih.gov/pubmed/32788669
http://dx.doi.org/10.1038/s41598-020-70386-3

Ejemplares similares